Analyst Ratings for Eagle Pharmaceuticals (EGRX)
EGRX Rating Summary
EGRX Price Target Summary
- Highest: $17.00 (Piper Sandler)
- Lowest: $17.00 (Piper Sandler)
- Average: $17.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$17.00 (+268.8%)
* Over Last 12-Mos
Rating Score: 4 / 10
Percentile Rank: 39%
Avg. $ Target:
$17.00 (+268.8%)
* Over Last 12-Mos
Rating Score: 4 / 10
Percentile Rank: 39%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/9/2023 | Piper Sandler | David Amsellem | Downgrade | Underweight (Neutral) |
17.00 (N/A) |
22.88 (4.61) |
-79.85% | Details |
| 4/7/2021 | RBC Capital » Updated 5/11/2021 |
Daniel Busb | New Coverage | Outperform (N/A) |
50.00 (52.00) |
41.28 (4.61) |
-88.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
